CONMED Corporation has shown a promising 18% share price growth on the NYSE. Trading below industry average PE ratio, it presents a good investment opportunity with an expected 88% earnings increase. Investors may consider accumulating more shares, while potential investors should analyze its balance sheet and potential risks.